ARTV Award Disclosure
Aslan Fred · SEC Form 4 · Filed Sep 15, 2026
Award
Calculated transaction value
$0
Aslan Fred Chief Executive Officer
ARTV
Transaction date
Sep 15, 2026
Public filing date
Sep 15, 2026
Filing lag
Filed same day
ARTV daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 110,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001193125-26-392025
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Artiva Biotherapeutics, Inc. ARTV Current | Award | Sep 15, 2026 | $0 |
| Artiva Biotherapeutics, Inc. ARTV | Award | Sep 15, 2026 | $0 |